Tomasz Figatowski
Overview
Explore the profile of Tomasz Figatowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blazejowska E, Zimodro J, Figatowski T, Brzeski A, Dziubich T, Parzuchowski J, et al.
Cardiol J
. 2023 Oct;
30(5):846-848.
PMID: 37822077
No abstract available.
2.
Januszek R, Bil J, Gilis-Malinowska N, Staszczak B, Figatowski T, Milewski M, et al.
Postepy Kardiol Interwencyjnej
. 2022 Aug;
18(1):14-26.
PMID: 35982740
Introduction: Data regarding the duration of dual antiplatelet therapy (DAPT) in patients with drug-eluting stent restenosis (DES-ISR) treated with percutaneous coronary intervention (PCI) and drug-eluting balloons (DEB) or DES are...
3.
Wanha W, Bil J, Kolodziejczak M, Kowalowka A, Kowalewski M, Hudziak D, et al.
Front Cardiovasc Med
. 2022 May;
9:849971.
PMID: 35615559
Background: Data regarding management of patients with unprotected left main coronary artery in-stent restenosis (LM-ISR) are scarce. Objectives: This study investigated the safety and effectiveness of percutaneous coronary intervention (PCI)...
4.
Wolny R, Kowalik I, Januszek R, Bil J, Figatowski T, Milewski M, et al.
Kardiol Pol
. 2022 Apr;
80(7-8):765-773.
PMID: 35445739
Background: There is limited data on the optimal revascularization strategy in patients with recurrent in-stent restenosis (R-ISR). Aims: To compare the long-term outcomes of patients treated with either a thin-strut...
5.
Wanha W, Tomaniak M, Wanczura P, Bil J, Januszek R, Wolny R, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407387
Background: Whereas the efficacy and safety of intravascular lithotripsy (IVL) have been confirmed in de novo calcified coronary lesions, little is known about its utility in treating stent underexpansion. This...
6.
Michalski T, Figatowski T, Jaguszewski M
Cardiol J
. 2022 Jan;
28(6):989-990.
PMID: 34985121
No abstract available.
7.
Piepiorka-Broniecka M, Michalski T, Figatowski T, Wojtowicz A, Jurowiecki J, Stanska A, et al.
Cardiol J
. 2021 Dec;
29(2):355-357.
PMID: 34897639
No abstract available.
8.
Bartus J, Januszek R, Hudziak D, Kolodziejczak M, Kuzma L, Tajstra M, et al.
J Clin Med
. 2021 Nov;
10(22).
PMID: 34830722
Data on the clinical outcomes comparing synthetic fluorocarbon polymer polytetrafluoroethylene- (PTFE, GraftMaster) and polyurethane- (Papyrus) covered stents (CSs) to seal coronary artery perforations (CAPs) are limited. We aimed to evaluate...
9.
Wanha W, Bil J, Januszek R, Gilis-Malinowska N, Figatowski T, Milewski M, et al.
Circ Cardiovasc Interv
. 2021 Sep;
14(9):e010868.
PMID: 34474584
[Figure: see text].
10.
Hudziak D, Targonski R, Wanha W, Gocol R, Hajder A, Parma R, et al.
Cardiol J
. 2021 Jul;
30(2):188-195.
PMID: 34308536
Background: The purpose of this study was to compare the safety and clinical outcomes of transcarotid (TC) and transapical access (TA) transcatheter aortic valve implantation (TAVI) patients whom the transfemoral...